Literature DB >> 23640490

Current genetics and epigenetics of smoking/tobacco-related cardiovascular disease.

Lutz P Breitling1.   

Abstract

Genetic and epigenetic factors are of great importance in cardiovascular biology and disease. Tobacco-smoking, one of the most important cardiovascular risk factors, is itself partially determined by genetic background and is associated with altered epigenetic patterns. This could render the genetics and epigenetics of smoking-related cardiovascular disease a textbook example of environmental epigenetics and modern approaches to multimodal data analysis. A pronounced association of smoking-related methylation patterns in the F2RL3 gene with prognosis in patients with stable coronary heart disease has recently been described. Nonetheless, surprisingly little concrete knowledge on the role of specific genetic variants and epigenetic modifications in the development of cardiovascular diseases in people who smoke has been accumulated. Beyond the current knowledge, the present review briefly outlines some chief challenges and priorities for moving forward in this field.

Entities:  

Keywords:  cardiovascular disease; epigenetics; genetics; methylation; tobacco-smoking

Mesh:

Substances:

Year:  2013        PMID: 23640490     DOI: 10.1161/ATVBAHA.112.300157

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  31 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

2.  The impact of genetic variation and cigarette smoke on DNA methylation in current and former smokers from the COPDGene study.

Authors:  Weiliang Qiu; Emily Wan; Jarrett Morrow; Michael H Cho; James D Crapo; Edwin K Silverman; Dawn L DeMeo
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

3.  An Epigenetics-Based, Lifestyle Medicine-Driven Approach to Stress Management for Primary Patient Care: Implications for Medical Education.

Authors:  Jenny Lee; Frank Papa; Paresh Atu Jaini; Sarah Alpini; Tim Kenny
Journal:  Am J Lifestyle Med       Date:  2019-05-09

Review 4.  The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.

Authors:  Iftikhar J Kullo; Nicholas J Leeper
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

5.  Epigenetic regulators of the revascularization response to chronic arterial occlusion.

Authors:  Joshua L Heuslein; Catherine M Gorick; Richard J Price
Journal:  Cardiovasc Res       Date:  2019-03-15       Impact factor: 10.787

6.  EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Rev Esp Escler Mult       Date:  2014-03

7.  Autoimmunity in the Abdominal Aortic Aneurysm and its Association with Smoking.

Authors:  M David Tilson
Journal:  Aorta (Stamford)       Date:  2017-12-01

8.  DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis.

Authors:  Lindsay M Reynolds; Ma Wan; Jingzhong Ding; Jackson R Taylor; Kurt Lohman; Dan Su; Brian D Bennett; Devin K Porter; Ryan Gimple; Gary S Pittman; Xuting Wang; Timothy D Howard; David Siscovick; Bruce M Psaty; Steven Shea; Gregory L Burke; David R Jacobs; Stephen S Rich; James E Hixson; James H Stein; Hendrik Stunnenberg; R Graham Barr; Joel D Kaufman; Wendy S Post; Ina Hoeschele; David M Herrington; Douglas A Bell; Yongmei Liu
Journal:  Circ Cardiovasc Genet       Date:  2015-08-25

Review 9.  Epigenetics in the development, modification, and prevention of cardiovascular disease.

Authors:  Thomas F Whayne
Journal:  Mol Biol Rep       Date:  2014-09-10       Impact factor: 2.316

10.  Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.

Authors:  Chengcheng Ji; Katsuya Nagaoka; Jing Zou; Sarah Casulli; Shaolei Lu; Kevin Y Cao; Hongyu Zhang; Yoshifumi Iwagami; Rolf I Carlson; Keri Brooks; Jonathan Lawrence; William Mueller; Jack R Wands; Chiung-Kuei Huang
Journal:  FASEB J       Date:  2018-09-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.